Natixis Becton Dickinson & CO Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Becton Dickinson & CO stock. As of the latest transaction made, Natixis holds 195,660 shares of BDX stock, worth $44.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

195,660

Previous 161,891 20.86%

Holding current value

$44.4 Million

Previous $37.8 Million 24.68%

% of portfolio

0.27%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$221.47 - $242.41 $7.48 Million - $8.19 Million	33,769 Added 20.86%	195,660 $47.2 Million
Q2 2024 Aug 13, 2024	BUY	$225.07 - $246.17 $12.3 Million - $13.5 Million	54,799 Added 51.17%	161,891 $37.8 Million
Q1 2024 May 13, 2024	SELL	$233.45 - $247.73 $29.1 Million - $30.9 Million	-124,539 Reduced 53.77%	107,092 $26.5 Million
Q4 2023 Feb 13, 2024	BUY	$232.24 - $267.23 $48.1 Million - $55.3 Million	206,949 Added 838.46%	231,631 $56.5 Million
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $8.59 Million - $9.56 Million	-33,707 Reduced 57.73%	24,682 $6.38 Million
Q2 2023 Aug 11, 2023	SELL	$238.39 - $265.32 $9.76 Million - $10.9 Million	-40,957 Reduced 41.23%	58,389 $15.4 Million
Q1 2023 May 12, 2023	SELL	$229.71 - $259.35 $35.3 Million - $39.8 Million	-153,617 Reduced 60.73%	99,346 $24.6 Million
Q4 2022 Feb 24, 2023	BUY	$218.29 - $256.91 $25 Million - $29.4 Million	114,362 Added 82.51%	252,963 $64.3 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $22.2 Million - $26.1 Million	101,779 Added 276.41%	138,601 $35.3 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $650,428 - $3.37 Million	12,746 Added 52.94%	36,822 $8.29 Million
Q2 2022 Aug 12, 2022	SELL	$234.74 - $275.42 $18.3 Million - $21.5 Million	-77,897 Reduced 76.39%	24,076 $5.94 Million
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $5.68 Million - $6.3 Million	23,293 Added 29.6%	101,973 $27.1 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $8.66 Million - $9.45 Million	-37,653 Reduced 32.37%	78,680 $19.8 Million
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $3.78 Million - $4.17 Million	-16,261 Reduced 12.26%	116,333 $28.6 Million
Q2 2021 Aug 13, 2021	BUY	$232.65 - $254.58 $1.93 Million - $2.11 Million	8,279 Added 6.66%	132,594 $32.2 Million
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $11.8 Million - $13.1 Million	-50,994 Reduced 29.09%	124,315 $30.2 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $38.9 Million - $43.1 Million	175,309 New	175,309 $43.9 Million
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $351,705 - $451,118	-1,630 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$219.9 - $263.41 $31.3 Million - $37.5 Million	-142,463 Reduced 98.87%	1,630 $380,000
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $28 Million - $39.9 Million	143,054 Added 13768.43%	144,093 $33.1 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $21.4 Million - $24.1 Million	-90,398 Reduced 98.86%	1,039 $281,000
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $21.1 Million - $23.4 Million	91,437 New	91,437 $23.1 Million
Q2 2019 Aug 13, 2019	SELL	$217.4 - $246.08 $2.7 Million - $3.05 Million	-12,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $2.56 Million - $3.08 Million	12,400 New	12,400 $3.06 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $6.95 Million - $7.63 Million	-29,804 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$208.1 - $233.85 $27.3 Million - $30.7 Million	-131,291 Reduced 81.5%	29,804 $7.14 Million
Q1 2018 May 15, 2018	BUY	$205.46 - $240.27 $8.48 Million - $9.91 Million	41,251 Added 34.42%	161,095 $34.9 Million
Q4 2017 Feb 14, 2018	BUY	$189.0 - $222.64 $14.6 Million - $17.2 Million	77,435 Added 182.59%	119,844 $25.7 Million
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $7.93 Million - $8.44 Million	42,409	42,409 $8.31 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account